Interference of flavonoids and carotenoids on the antimicrobial activity of some drugs against clinical isolates of Pseudomonas aeruginosa

被引:0
|
作者
Dos Santos, R. [1 ,6 ]
Pimenta-Freire, G. [2 ]
Figueiredo, F. J. B. [3 ,4 ,6 ]
Dias-Souza, M., V [5 ,6 ]
机构
[1] Univ Fed Minas Gerais, Food Sci, Fac Pharm, Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Fac Pharm, Belo Horizonte, MG, Brazil
[3] Santo Agostinho Inst, Hlth & Human Dev Fac, Teresina, PI, Brazil
[4] Fundacao Oswaldo Cruz, Rene Rachou Res Ctr, Rio De Janeiro, Brazil
[5] Univ Fed Minas Gerais, Biol Sci Inst, Belo Horizonte, MG, Brazil
[6] Integrated Pharmacol & Drug Interact Res Grp GPqF, Belo Horizonte, MG, Brazil
来源
INTERNATIONAL FOOD RESEARCH JOURNAL | 2016年 / 23卷 / 03期
关键词
Interactions; Antimicrobials; Carotenoids; Flavonoids;
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The use of phytonutrients in pharmaceutical dosage forms aiming a healthier lifestyle has increased worldwide, and in spite of being generally an useful healthcare measure, this is not free of risks when concomitant medication use is considered. The combined use of phytonutrients and medication remains poorly investigated, and represents a serious problem in drug therapy, given that side effects due to drug-nutrient interactions are poorly predictable. In this study, three drugs were tested in combination to lycopene beta-carotene (carotenoids), diosmin and curcumin (flavonoids) against clinical isolates of P. aeruginosa. Strains identity was confirmed by automated methods and the interference of phytomolecules on the pharmacological activity of the chosen drugs was assessed in vitro using antimicrobial disks. Here we show that lycopene, beta-carotene, diosmin and curcumin can act synergistically when combined to antimicrobial drugs against clinical isolates of P. aeruginosa. In vivo studies are necessary for assessing the biological effects of these interactions considering clinical contexts. (C) All Rights Reserved
引用
收藏
页码:1268 / 1273
页数:6
相关论文
共 50 条
  • [1] Carotenoids and flavonoids can impair the effectiveness of some antimicrobial drugs against clinical isolates of Escherichia coli and Staphylococcus aureus
    Dos Santos, R.
    Pimenta-Freire, G.
    Dias-Souza, M., V
    [J]. INTERNATIONAL FOOD RESEARCH JOURNAL, 2015, 22 (05): : 1777 - 1782
  • [2] Antimicrobial susceptibility testings against clinical mucoid Pseudomonas aeruginosa isolates
    Horii, T.
    [J]. 26TH INTERNATIONAL CONGRESS OF CHEMOTHERAPY AND INFECTION (ICC), 2009, : 119 - 122
  • [3] Antimicrobial susceptibility testings against clinical mucoid Pseudomonas aeruginosa isolates
    Horii, T.
    [J]. NEW APPROACHES IN CORONARY ARTERY DISEASE: PROCEEDINGS OF THE 8TH INTERNATIONAL CONGRESS ON CORONARY ARTERY DISEASE, 2009, : 119 - 122
  • [4] Antimicrobial activity of different Lactobacillus species against multidrug resistant clinical isolates of Pseudomonas aeruginosa
    Jamalifar, H.
    Rahimi, H. R.
    Samadi, N.
    Shahverdi, A. R.
    Sharifian, Z.
    Hosseini, F.
    Eslahi, H.
    Fazeli, M. R.
    [J]. IRANIAN JOURNAL OF MICROBIOLOGY, 2011, 3 (01) : 21 - 25
  • [5] Dexamethasone abrogates the antimicrobial and antibiofilm activities of different drugs against clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa
    Rodrigues, Aquila
    Gomes, Andre
    Ferreira Marcal, Pedro Henrique
    Dias-Souza, Marcus Vinicius
    [J]. JOURNAL OF ADVANCED RESEARCH, 2017, 8 (01) : 55 - 61
  • [6] Morpholinium-based ionic liquids show antimicrobial activity against clinical isolates of Pseudomonas aeruginosa
    Clapa, Tomasz
    Michalski, Jakub
    Syguda, Anna
    Narozna, Dorota
    van Oostrum, Peter
    Reimhult, Erik
    [J]. RESEARCH IN MICROBIOLOGY, 2021, 172 (03)
  • [7] Evaluation and study of antimicrobial activity of nanoliposomal meropenem against Pseudomonas aeruginosa isolates
    Zahra, Momeni-Javid
    Hamed, Hamishekar
    Mohammad, Rahmati-Yamchi
    Nosratollah, Zarghami
    Akbarzadeh, Abolfazl
    Morteza, Milani
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2017, 45 (05) : 975 - 980
  • [8] Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa
    Al-Jasser, AM
    Elkhizzi, NA
    [J]. SAUDI MEDICAL JOURNAL, 2004, 25 (06) : 780 - 784
  • [9] Antimicrobial Activity of Murepavadin Tested against Clinical Isolates of Pseudomonas aeruginosa from the United States, Europe, and China
    Sader, Helio S.
    Dale, Glenn E.
    Rhomberg, Paul R.
    Flamm, Robert K.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (07)
  • [10] Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates
    Diez-Aguilar, Maria
    Hernandez-Garcia, Marta
    Morosini, Maria-Isabel
    Fluit, Ad
    Tunney, Michael M.
    Huertas, Natalia
    del Campo, Rosa
    Obrecht, Daniel
    Bernardini, Francesca
    Ekkelenkamp, Miquel
    Canton, Rafael
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (04) : 984 - 992